CROSSROADS STRATEGIES, LLC for BRISTOL-MYERS SQUIBB
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of 21st Century Cures Act (P.L.114-255). S.204/H.R.878, Trickett Wendler Right to Try Act of 2017. H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017. Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program and truthful non-misleading industry communications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid, such as: Part D Medicare Program (including Coverage Gap, IPAB Repeal and other offsets in H.R.1892/P.L.115-123, Bipartisan Budget Act of 2018), Medicare Part B reimbursement and CMS rule related to next generation sequencing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Budget/Appropriations BUD
H.R.3268/S.1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018; H.R.1370, Further Additional Continuing Appropriations Act, 2018 (P.L.115-96); H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123); H.R.1625, Consolidated Appropriations Act, 2018 (P.L.115-141); Food and Drug Administration (FDA) related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Taxation/Internal Revenue Code TAX
Implementation of H.R.1, Tax Cuts and Jobs Act (P.L.115-97).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.